Laparoscopic Pyelolithotomy Versus Percutaneous Nephrolothotomy for Management of >3cm Renal Pelvis Stone

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Shiraz University of Medical Sciences.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Alireza Aminsharifi, Shiraz University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01637337
First received: July 3, 2012
Last updated: July 13, 2012
Last verified: July 2012
  Purpose

To compare the outcome of laparoscopic pyelolithotomy with percutaneous nephrolithotomy in patients with >3cm renal pelvis stone.


Condition Intervention Phase
Renal Pelvis Stone >3cm
Procedure: laparoscopic pyelolithotomy
Procedure: percutaneous nephrolithotomy
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by Shiraz University of Medical Sciences:

Primary Outcome Measures:
  • Stone free rate [ Time Frame: at least 6 month after surgery ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 60
Study Start Date: May 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: laparoscopic pyelolithotomy Procedure: laparoscopic pyelolithotomy
laparoscopy
Sham Comparator: percutaneous nephrolithotomy Procedure: percutaneous nephrolithotomy
percutaneous nephrolithotomy

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults with >3cm renal pelvis stone

Exclusion Criteria:

  • History of previous surgery on the target kidney
  • Active UTI
  • Coagulopathy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01637337

Locations
Iran, Islamic Republic of
Shiraz University of Medical Sciences Recruiting
Shiraz, Fars, Iran, Islamic Republic of, 71344
Contact: Alireza Aminsharifi, MD    9177000656 ext 0098    aminsharifi_ar@yahoo.com   
Principal Investigator: Alireza Aminsharifi, MD         
Sponsors and Collaborators
Shiraz University of Medical Sciences
  More Information

No publications provided

Responsible Party: Alireza Aminsharifi, Assistant Professor of Urology, Shiraz University of Medical Sciences
ClinicalTrials.gov Identifier: NCT01637337     History of Changes
Other Study ID Numbers: 89-01-01-2391
Study First Received: July 3, 2012
Last Updated: July 13, 2012
Health Authority: Iran: Ministry of Health

ClinicalTrials.gov processed this record on July 26, 2014